Ellington Management Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-20,100
| Closed | -$131K | – | 728 |
|
|
2018
Q1 | $131K | Buy |
+20,100
| New | +$131K | 0.01% | 756 |
|
|
2017
Q2 | – | Sell |
-12,200
| Closed | -$113K | – | 820 |
|
|
2017
Q1 | $113K | Sell |
12,200
-9,000
| -42% | -$83.4K | ﹤0.01% | 628 |
|
|
2016
Q4 | $177K | Buy |
21,200
+4,300
| +25% | +$35.9K | 0.03% | 449 |
|
|
2016
Q3 | $116K | Buy |
16,900
+5,900
| +54% | +$40.5K | 0.03% | 601 |
|
|
2016
Q2 | $54K | Buy |
+11,000
| New | +$54K | 0.08% | 239 |
|
|
2015
Q3 | – | Sell |
-28,068
| Closed | -$590K | – | 836 |
|
|
2015
Q2 | $590K | Buy |
28,068
+21,068
| +301% | +$443K | 0.14% | 196 |
|
|
2015
Q1 | $294K | Buy |
+7,000
| New | +$294K | 0.06% | 469 |
|